Thrombosis formation on atherosclerotic lesions and plaque rupture
- PMID: 25156650
- DOI: 10.1111/joim.12296
Thrombosis formation on atherosclerotic lesions and plaque rupture
Abstract
Atherosclerosis is a silent chronic vascular pathology that is the cause of the majority of cardiovascular ischaemic events. The evolution of vascular disease involves a combination of endothelial dysfunction, extensive lipid deposition in the intima, exacerbated innate and adaptive immune responses, proliferation of vascular smooth muscle cells and remodelling of the extracellular matrix, resulting in the formation of an atherosclerotic plaque. High-risk plaques have a large acellular lipid-rich necrotic core with an overlying thin fibrous cap infiltrated by inflammatory cells and diffuse calcification. The formation of new fragile and leaky vessels that invade the expanding intima contributes to enlarge the necrotic core increasing the vulnerability of the plaque. In addition, biomechanical, haemodynamic and physical factors contribute to plaque destabilization. Upon erosion or rupture, these high-risk lipid-rich vulnerable plaques expose vascular structures or necrotic core components to the circulation, which causes the activation of tissue factor and the subsequent formation of a fibrin monolayer (coagulation cascade) and, concomitantly, the recruitment of circulating platelets and inflammatory cells. The interaction between exposed atherosclerotic plaque components, platelet receptors and coagulation factors eventually leads to platelet activation, aggregation and the subsequent formation of a superimposed thrombus (i.e. atherothrombosis) which may compromise the arterial lumen leading to the presentation of acute ischaemic syndromes. In this review, we will describe the progression of the atherosclerotic lesion along with the main morphological characteristics that predispose to plaque rupture, and discuss the multifaceted mechanisms that drive platelet activation and subsequent thrombus formation. Finally, we will consider the current scientific challenges and future research directions.
Keywords: atherosclerosis; atherosclerotic plaque; coagulation; lipids; platelets; thrombosis.
© 2014 The Association for the Publication of the Journal of Internal Medicine.
Similar articles
-
Pathophysiology of atherosclerosis plaque progression.Heart Lung Circ. 2013 Jun;22(6):399-411. doi: 10.1016/j.hlc.2013.03.001. Epub 2013 Mar 29. Heart Lung Circ. 2013. PMID: 23541627 Review.
-
Update on acute coronary syndromes: the pathologists' view.Eur Heart J. 2013 Mar;34(10):719-28. doi: 10.1093/eurheartj/ehs411. Epub 2012 Dec 13. Eur Heart J. 2013. PMID: 23242196 Review.
-
[Pathology of AtheroThrombosIS (ATIS)].Drugs. 2010 Nov 1;70 Suppl 1:3-8. doi: 10.2165/00000004-000000000-00000. Drugs. 2010. PMID: 20977286 Review. Japanese.
-
Atherosclerotic plaque rupture and thrombosis. Evolving concepts.Circulation. 1990 Sep;82(3 Suppl):II47-59. Circulation. 1990. PMID: 2203564 Review.
-
Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI.FASEB J. 2005 Jun;19(8):898-909. doi: 10.1096/fj.04-2748com. FASEB J. 2005. PMID: 15923400
Cited by
-
Multi‑label classification of biomedical data.Med Int (Lond). 2024 Sep 9;4(6):68. doi: 10.3892/mi.2024.192. eCollection 2024 Nov-Dec. Med Int (Lond). 2024. PMID: 39301328 Free PMC article.
-
Slounase, a Batroxobin Containing Activated Factor X Effectively Enhances Hemostatic Clot Formation and Reducing Bleeding in Hypocoagulant Conditions in Mice.Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211018510. doi: 10.1177/10760296211018510. Clin Appl Thromb Hemost. 2021. PMID: 34047195 Free PMC article.
-
Platelets in Healthy and Disease States: From Biomarkers Discovery to Drug Targets Identification by Proteomics.Int J Mol Sci. 2020 Jun 25;21(12):4541. doi: 10.3390/ijms21124541. Int J Mol Sci. 2020. PMID: 32630608 Free PMC article. Review.
-
Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation.Sci Rep. 2016 May 4;6:25171. doi: 10.1038/srep25171. Sci Rep. 2016. PMID: 27142573 Free PMC article.
-
Mechanisms of the Osteogenic Switch of Smooth Muscle Cells in Vascular Calcification: WNT Signaling, BMPs, Mechanotransduction, and EndMT.Bioengineering (Basel). 2020 Aug 6;7(3):88. doi: 10.3390/bioengineering7030088. Bioengineering (Basel). 2020. PMID: 32781528 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous